Mark Ericson

DEPT.:Medicinal Chemistry
YEAR OF GRAD STUDY: 2007-2012

MENTOR(S): Kevin Rice 
SOURCE(S) OF SUPPORT: NIH T32, PI Grants, AFPE, College of Pharmacy (UI)

EDUCATION:
Carleton College BA 2006 Chemistry
University of Iowa (UI) PhD 2012 Medicinal Chemistry

HONORS:
American Peptide Symposium Travel Grant (2015),
University of Iowa College of Pharmacy Dissertation Award Fellow (2012),
MNPC Graduate Student Travel Award (2012),
AFPE Fellowship (2009-2012),
NIH Predoctoral Fellowship in Biotechnology (2008-2011),
University of Iowa MNPC Fellowship (2007-2008)

TEACHING EXPERIENCE:
Teaching Assistant, Carleton College (2005-2006)

RESEARCH EXPERIENCE (prior to entering program): 
Undergraduate Research Assistant in laboratory Dr. Paul Hergenrother, University of Illinois (Summer 2005)

CURRENT RESEARCH ACTIVITIES (brief description): 

COURSES TAKEN (this graduate program): 
I am currently pursuing postdoctoral studies in the laboratory of Dr. Carrie Haskell-Luevano at the University of Minnesota, investigating the melanocortin receptor system as it relates to food intake and energy homeostasis.

POSTDOCTORAL TRAINING APPLIED FOR, UNDERWAY, OR COMPLETED:
University of Minnesota  Dr. Carrie Haskell-Luevano Melanocortin Receptors  November 2012  May 2013      

APPLICATION(S) FOR POSTDOCTORAL FUNDING (BUT THIS PROGRAM):
NIH F-32 Individual Postdoctoral Fellowship NRSA Funding to begin December 1, 2015
American Diabetes Association Postdoctoral Fellowship Decision pending (will be declined due to NIH funding)
American Heart Association Postdoctoral Fellowship Decision pending (will be declined due to NIH funding)
American Foundation for Pharmaceutical Education  Funded 2009-2012
NIH Predoctoral Fellowship in Biotechnology Funded 2008-2011
UI College of Pharmacy Dissertation Award Funded 2012

PUBLICATIONS: 

Ericson MD, Schnell SM, Freeman KT, Haskell-Luevano C. A Fragment of the Escherichia coli ClpB Heat-Shock Protein is a Micromolar Melanocortin 1 Receptor Agonist. Bioorg. Med. Chem. Lett. 2015, In revisions.
Ericson MD, Wilczynski A, Sorensen N, Xiang Z, and Haskell-Luevano C. Discovery of a β-hairpin octapeptide mimetic of AGRP(87-132) with equipotent mMC4R antagonist pharmacology. J. Med. Chem. 2015, 58, 4638-4647.
Ericson MD, Rice KG, and Zuber G. Macromolecular conjugates for nucleic acid delivery.  Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology (ed. Daniel Scherman). Imperial College Press, 2014, London.
Ericson MD and Rice KG. A convergent synthesis of homogeneous reducible polypeptides. Tetrahedron Letters. 2013, 54, 4746-4748.
Khargharia S, Kizzire K, Ericson MD, Baumhover NJ, and Rice KG. PEG length and chemical linkage controls polyacridine peptide DNA polyplex pharmacokinetics, biodistribution, metabolic stability and in vivo gene expression. Journal of Controlled Release. 2013, 170, 325-333.
Ericson MD and Rice KG. Iterative reducible ligation to form homogeneous penicillamine cross-linked polypeptides. Tetrahedron Letters. 2013, 54, 3440-3443.
Ericson MD and Rice KG.  Synthesis of homogeneous disulfide cross-linked polypeptides by iterative reducible ligation.  Peptide Science.  2012, 98, 510-517.
Fernandez CA, Baumhover NJ, Duskey JT, Khargharia S, Kizzire K, Ericson MD, and Rice KG.  Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver.  Gene Therapy 2011, 18, 23-37.
Tantbirojn D, Huang A, Ericson MD, and Poolthong S.  Change in surface hardness of enamel by a cola drink and CPP-ACP paste.  Journal of Dentistry 2008, 36, 74-79.